Pharma & Healthcare

Supply chain

How value flows from raw inputs to the end customer.

1. 1
   Raw MaterialsProcurement of basic chemical and biological inputs for drug production

   Operated by: Chemical suppliers, agricultural producers

   ▶

   In simple termsThink of it like a bakery that makes bread. The raw materials are the flour, eggs, and sugar they buy to make their cakes. In pharma, this is like buying the basic ingredients to make medicine.

   What it is

   These businesses provide the basic ingredients or components needed to make medicines. They might sell things like chemicals, plant extracts, or other substances that drug companies use to create finished products.

   How it makes money

   They earn money by selling these raw materials to pharmaceutical companies. The more they can produce and sell at a good price, the more profit they make.

   Where it sits in the chain

   Upstream: They buy from chemical manufacturers or agricultural suppliers. Downstream: They sell to pharmaceutical companies that make finished drugs.

   Who plays here

   Companies that specialize in producing chemicals, plant-based ingredients, or synthetic compounds used in drug manufacturing. Some may also be involved in sourcing and processing natural materials like herbs or minerals.

   Economics & margins

   They have moderate costs for production and storage. They need some capital to set up facilities but not as much as drug manufacturers. Margins are usually average, and they can be affected by changes in the price of chemicals or demand from pharma companies.

   What a strong player looks like

   A strong player has long-term contracts with big pharma companies, stable pricing for their materials, and the ability to adapt to new regulations or industry trends.

   Metrics that matter

   • Volume of raw materials sold
   • Price per unit of material
   • Cost of production relative to selling price

   Key risks

   • Fluctuations in chemical prices
   • Supply chain disruptions
   • Decreased demand from pharmaceutical firms
   • Regulatory changes affecting what can be used as a raw material
2. 2
   API / Bulk DrugsProduction of active pharmaceutical ingredients and intermediates

   Operated by: API manufacturers, bulk drug producers

   ▶

   In simple termsImagine you're making cookies. The bulk drugs are like the flour and sugar you buy in big bags to make the actual cookies later.

   What it is

   API / Bulk Drugs companies produce the basic chemical ingredients (called Active Pharmaceutical Ingredients) that go into medicines. These are not yet pills or syrups — they’re the raw materials used by other companies to make finished drugs.

   How it makes money

   These companies sell their chemicals in bulk to drug manufacturers, who then turn them into tablets, injections, or creams. They earn money by selling large quantities of these chemicals at a price that covers their costs and gives them a profit.

   Where it sits in the chain

   Upstream: they buy raw materials like chemicals and energy from suppliers. Downstream: they sell to pharmaceutical companies that make finished medicines.

   Who plays here

   These are chemical manufacturing companies, often with expertise in organic chemistry. Some may be owned by larger pharma firms or operate independently, supplying many different drug makers.

   Economics & margins

   They need a lot of capital for plants and equipment (capital intensive). Their costs include raw materials, energy, and labor. Margins can be low due to competition but are stable if they have long-term contracts. They may face price fluctuations based on global supply of chemicals.

   What a strong player looks like

   A strong player has long-term contracts with big pharma companies, stable production costs, and consistent sales volume. It can adapt to new regulations and has a good reputation for quality.

   Metrics that matter

   • Volume of API produced and sold
   • Gross margin percentage
   • Contract backlog or order book size

   Key risks

   • Price wars with competitors
   • Regulatory changes in chemical safety
   • Supply chain disruptions for raw materials
   • Dependence on a few large customers
3. 3
   FormulationsConversion of APIs into final dosage forms for patient use

   Operated by: Pharmaceutical companies (both innovators and generic manufacturers)

   ▶

   In simple termsImagine you're making cookies. The 'formulations' part is like mixing the ingredients (like flour, sugar, and eggs) to make the cookie dough — it's where they turn raw materials into something useful.

   What it is

   Formulations are companies that take active pharmaceutical ingredients (APIs), which are the main medicine chemicals, and mix them with other safe substances to create finished medicines like tablets, syrups, or creams. They make sure the medicine is easy to use, safe, and works as intended.

   How it makes money

   These companies sell their finished medicines directly to hospitals, pharmacies, and doctors. They earn money by selling each unit of medicine at a price higher than what they paid for the ingredients and production costs.

   Where it sits in the chain

   Upstream: They buy APIs from manufacturers or suppliers. Downstream: They sell finished medicines to healthcare providers, retailers, and sometimes directly to patients through online platforms.

   Who plays here

   These are typically mid-sized to large pharmaceutical companies that focus on creating branded or generic medicines. Some may also be contract manufacturing organizations (CMOs) that make medicines for other companies.

   Economics & margins

   They have moderate costs because they need to buy APIs and packaging materials, but not as much as API manufacturers. They require some capital for production facilities and marketing. Margins are usually good if the medicine is in demand, but can be affected by competition and pricing regulations.

   What a strong player looks like

   A strong player has a stable portfolio of well-known medicines, consistent sales growth, good relationships with healthcare providers, and the ability to launch new products successfully. They also have efficient operations and can adapt to changes in regulations or market demand.

   Metrics that matter

   • Sales volume of each product
   • Gross profit margin
   • Market share in key therapeutic areas
   • Number of new products launched annually

   Key risks

   • Regulatory changes that affect pricing or approval
   • Competition from generic versions of their medicines
   • Supply chain disruptions for APIs or packaging materials
   • Failure of a major drug to gain market acceptance
4. 4
   Packaging & LabelingPreparation of finished products for distribution

   Operated by: Packaging firms, contract packagers

   ▶

   In simple termsImagine you're wrapping a gift for someone. Packaging & Labeling is like putting the medicine into a box and writing on it what's inside, so the doctor or patient knows exactly what they're getting.

   What it is

   Packaging & Labeling involves taking finished medicines and putting them into containers (like bottles, boxes, or blister packs) with clear labels that show the name of the drug, dosage, instructions, and other important info. This is done by companies that specialize in making these packages and printing the labels.

   How it makes money

   These companies earn money by selling packaging materials to pharmaceutical companies. They might also charge for customizing labels with specific information about each medicine.

   Where it sits in the chain

   Upstream, they buy raw materials like plastic, paper, ink, and adhesives. Downstream, they sell finished packages and labeled products to pharmaceutical manufacturers or distributors.

   Who plays here

   These are companies that specialize in making packaging materials (like bottles, boxes) and printing labels. Some may also handle the actual assembly of the package with the medicine inside. They can be small local firms or larger regional players focused on this specific part of the supply chain.

   Economics & margins

   The cost structure includes raw materials, machinery for printing and assembling, labor, and quality control. It's not very capital-intensive compared to drug manufacturing but still requires some investment in equipment. Margins are moderate, and there is little cyclicality since packaging is always needed regardless of the economy.

   What a strong player looks like

   A strong player has consistent quality, reliable delivery times, good relationships with pharmaceutical companies, and the ability to adapt quickly to new regulations or customer needs.

   Metrics that matter

   • Number of packages produced per month
   • Cost per unit package
   • On-time delivery rate
   • Defect or rejection rate

   Key risks

   • Supply chain disruptions for raw materials
   • Regulatory changes in labeling requirements
   • Competition from cheaper local or international suppliers
   • Quality control issues leading to recalls
5. 5
   DistributionTransportation and delivery of pharmaceuticals to end points

   Operated by: Wholesalers, distributors, logistics companies

   ▶

   In simple termsImagine a delivery truck that brings toys from the toy factory to the toy store, so kids can buy them. Distribution is like that, but for medicines and healthcare products.

   What it is

   Distribution in pharma & healthcare means getting medicines, medical devices, or health products from manufacturers to hospitals, clinics, pharmacies, and even homes. These companies act as middlemen who make sure the right product reaches the right place on time.

   How it makes money

   They earn money by selling the products they distribute at a slightly higher price than what they bought them for. They also charge fees for storage, delivery, and sometimes for managing inventory for their customers.

   Where it sits in the chain

   Upstream: manufacturers (like drug companies) who make medicines. Downstream: hospitals, pharmacies, clinics, and sometimes even patients who buy the products directly.

   Who plays here

   There are large national distributors that work with many brands and cover the whole country; regional or local distributors that focus on specific areas; and specialized distributors that handle only certain types of products like vaccines or medical devices.

   Economics & margins

   Distribution has low capital intensity (not too much money needed to start), but it depends heavily on logistics. Margins are usually small, around 5-10%, and the business can be affected by changes in government policies or supply chain issues.

   What a strong player looks like

   A strong distributor has a reliable delivery system, good relationships with both manufacturers and customers, and can handle large volumes without losing money. They also adapt quickly to changes in the market.

   Metrics that matter

   • Inventory turnover ratio
   • Gross margin percentage
   • Number of customers served
   • On-time delivery rate

   Key risks

   • Supply chain disruptions (like delays in product shipments)
   • Regulatory changes that affect how products are sold
   • Competition from larger players with better logistics
   • Stockouts or overstocking due to poor planning
6. 6
   Retail / DispensingSale of medicines through pharmacies and retail outlets

   Operated by: Pharmacies, drug stores, e-commerce platforms

   ▶

   In simple termsImagine a store where people go to buy toys, but instead they're buying medicine. The store has all the medicines and helps you find what you need.

   What it is

   Retail / Dispensing is when pharmacies or drugstores sell medicines directly to patients. These stores have a wide range of medicines, some over-the-counter (OTC) and others that require a doctor's prescription.

   How it makes money

   They make money by selling medicines at a price higher than what they paid for them. They also earn from other health products like bandages, thermometers, or vitamins.

   Where it sits in the chain

   Upstream: They buy medicines from manufacturers or distributors. Downstream: They sell to patients and sometimes to clinics or small hospitals.

   Who plays here

   There are independent pharmacies, chain drugstores (like a group of stores with the same name), and online pharmacy platforms that deliver medicine to homes.

   Economics & margins

   They have low capital needs compared to manufacturers but need good inventory management. Margins are usually modest, around 10-20%. They can be affected by changes in regulations or competition.

   What a strong player looks like

   A strong player has a wide range of products, loyal customers, efficient operations, and can adapt to new trends like online orders or health services.

   Metrics that matter

   • Number of stores
   • Average revenue per store
   • Inventory turnover rate
   • Customer footfall or online orders

   Key risks

   • Regulatory changes that affect medicine sales
   • Competition from large chains or online platforms
   • Supply chain disruptions for medicines
   • Decreasing margins due to price controls
7. 7
   Hospitals & ClinicsAdministration of drugs and medical treatments to patients

   Operated by: Hospital chains, clinics, diagnostic centers

   ▶

   In simple termsThink of hospitals and clinics like a big restaurant that serves sick people instead of food. They help people feel better by giving them care, just like a restaurant helps you eat.

   What it is

   Hospitals and clinics are places where doctors and nurses treat patients who are sick or injured. They provide services like check-ups, surgeries, tests, and medicines to help people get well.

   How it makes money

   They earn money by charging patients for the care they receive, such as doctor visits, lab tests, and hospital stays. Some also get money from insurance companies that cover part of the cost.

   Where it sits in the chain

   Hospitals and clinics buy medicines and medical equipment from manufacturers and suppliers (upstream). They sell their services directly to patients or through health insurance companies (downstream).

   Who plays here

   There are large private hospital chains, small local clinics, government-run hospitals, and specialized centers like cancer treatment facilities. Some also offer telemedicine services.

   Economics & margins

   They have high costs because they need buildings, equipment, and staff. They require a lot of money upfront (capital intensive). Their profit margins can be moderate to low due to competition and rising expenses.

   What a strong player looks like

   A strong hospital has a good reputation, many satisfied patients, modern equipment, and stable finances. It can handle emergencies well and keeps costs under control.

   Metrics that matter

   • Number of patients treated per month
   • Average cost per patient visit
   • Bed occupancy rate
   • Patient satisfaction scores

   Key risks

   • High operating costs that are hard to control
   • Regulatory changes affecting how they operate
   • Competition from other hospitals or clinics
   • Difficulty in collecting payments from patients or insurers
8. 8
   DiagnosticsTesting for disease detection and health monitoring

   Operated by: Diagnostic labs, imaging centers, point-of-care device manufacturers

   ▶

   In simple termsDiagnostics is like a detective who checks if someone is sick by looking at clues, like blood or body parts, to find out what's wrong.

   What it is

   Diagnostics companies test samples from patients—like blood, urine, or tissue—to find out if they have diseases. They use machines and lab tests to look for signs of illness.

   How it makes money

   They charge hospitals, clinics, and doctors for running these tests. Some also sell the equipment used in labs, like microscopes or testing kits.

   Where it sits in the chain

   Upstream: They buy chemicals, reagents, and machines from manufacturers. Downstream: They sell test results to hospitals, clinics, and sometimes directly to patients.

   Who plays here

   There are big lab chains that run many tests, smaller local labs, companies that make diagnostic equipment, and firms that provide testing services in remote areas using mobile units.

   Economics & margins

   They need expensive machines and trained staff. Their costs include reagents, maintenance, and labor. Margins can be good if they have a lot of customers, but they are sensitive to changes in healthcare spending or regulations.

   What a strong player looks like

   A strong diagnostics company has a large, loyal customer base of doctors and hospitals, uses modern technology, keeps costs low, and can adapt quickly to new medical trends or regulations.

   Metrics that matter

   • Number of tests performed per month
   • Cost per test
   • Customer retention rate (how often doctors use their services)
   • Profit margin on each test

   Key risks

   • Regulatory changes that affect how tests can be done
   • Competition from cheaper labs or new technologies
   • Supply chain issues for reagents and equipment
   • Decreased patient volume due to economic downturns
9. 9
   Health InsuranceCoverage of medical expenses through insurance plans

   Operated by: Insurance companies, third-party administrators

   ▶

   In simple termsHealth insurance is like a safety net that helps you pay for doctor visits and medicines if you get sick, just like how a raincoat keeps you dry when it rains.

   What it is

   Health insurance companies provide financial protection to people by covering the cost of medical treatments, hospital stays, and sometimes even preventive care. They help individuals or groups pay for healthcare expenses that can be very expensive.

   How it makes money

   These companies collect regular payments called premiums from customers. When a customer needs medical care, the insurance company pays part or all of the costs, as long as it's covered by their plan. The company makes money if the total amount paid in claims is less than what they collected in premiums.

   Where it sits in the chain

   Upstream: They buy coverage plans and risk management tools from reinsurers and healthcare providers. Downstream: They sell policies to individuals, families, or businesses through agents, brokers, or online platforms.

   Who plays here

   ['Private health insurance companies that offer individual and group plans', "Public sector insurers like the Employees' State Insurance Corporation (ESIC) that serve specific groups such as workers", 'Third-party administrators who handle claims processing for insurance companies']

   Economics & margins

   Health insurance companies have moderate costs, mostly related to customer service, claims processing, and administrative work. They are not very capital-intensive but need strong risk management systems. Profit margins can vary widely depending on how well they manage claims and pricing, and the industry is somewhat sensitive to economic downturns as people may drop coverage.

   What a strong player looks like

   A strong health insurance company has a large, stable customer base, low claim ratios, good relationships with hospitals and doctors, and clear communication about what is covered. It also adapts well to changes in healthcare costs and regulations.

   Metrics that matter

   • Premium income (how much money they collect from customers)
   • Claim ratio (percentage of premiums paid out in medical expenses)
   • Customer retention rate (how many people keep their insurance over time)

   Key risks

   • High claim ratios that eat into profits
   • Rising healthcare costs that make it harder to price policies accurately
   • Regulatory changes that affect what they can cover or how much they can charge
   • Customer churn if people switch to cheaper or better plans

Sub-sectors

Every part of the sector, broken down. Nesting shows what splits further.

• FormulationsManufacture of finished medicinal products for patient use

  ▶

  In simple termsImagine a bakery that makes different kinds of bread and cakes using flour, sugar, and eggs — but they don't grow the wheat or raise the chickens. They just mix the ingredients to make tasty treats for people.

  What it is

  Formulations are companies that take active medicines (like chemicals) and turn them into finished products like tablets, syrups, or creams that patients can use. These companies don’t create the basic medicine themselves — they just prepare it in a way that’s safe and easy to take.

  How it makes money

  They sell these finished medicines to hospitals, pharmacies, and doctors. They make money by charging more for the final product than what they paid for the ingredients and production costs.

  Where it sits in the chain

  Upstream: They buy raw materials like chemicals, packaging, and sometimes active pharmaceutical ingredients (APIs) from other companies. Downstream: They sell their finished medicines to pharmacies, hospitals, and healthcare providers.

  Who plays here

  These are typically mid-sized or large drug manufacturers that focus on making ready-to-use medicines. Some may also have their own research teams for developing new formulations, but many rely on existing formulas created by others.

  Economics & margins

  They have moderate costs — not too high because they don’t make the basic medicine themselves, but still need to invest in packaging and quality control. They operate with average profit margins (around 10-20%), and their business can be affected by changes in regulations or competition.

  What a strong player looks like

  A strong player has a wide range of reliable, high-quality products; consistent sales growth; good relationships with healthcare providers; and the ability to adapt quickly to new regulations or market trends.

  Metrics that matter

  • Sales growth
  • Gross margin percentage
  • Number of products in portfolio
  • Market share in key therapeutic areas

  Key risks

  • Regulatory changes that affect how medicines are approved
  • Competition from cheaper generic drugs
  • Supply chain disruptions for raw materials
  • Price pressures from large buyers like hospitals or governments
  • Innovator / R&D-DrivenDevelop new drugs with proprietary intellectual property

    ▶

    In simple termsImagine you're making a new kind of cookie that no one has ever tried before. You spend time figuring out the best way to mix the ingredients so it's super tasty and healthy. That's what these companies do, but with medicines instead of cookies.

    What it is

    These are companies that focus on creating new medicines by doing a lot of scientific research. They design and test new drugs to treat diseases in ways that haven't been done before.

    How it makes money

    They sell the new medicines they develop, often at higher prices because they're unique. They also get money from selling patents or licensing their discoveries to other companies.

    Where it sits in the chain

    Upstream: They buy chemicals and lab equipment. Downstream: They sell medicines directly to hospitals, pharmacies, and doctors.

    Who plays here

    Companies that invest heavily in research labs, hire scientists, and focus on developing new drugs rather than just making generic versions of old ones.

    Economics & margins

    They have high costs because research is expensive and takes a long time. They need a lot of money upfront but can make big profits if their drug works well. Their earnings can be unstable because not all research leads to successful medicines.

    What a strong player looks like

    A company that has many new medicines in development, spends a lot of money on research, and has a strong team of scientists who are consistently making breakthroughs.

    Metrics that matter

    • Number of new drugs approved per year
    • R&D spending as a percentage of revenue
    • Profit margin on new products

    Key risks

    • Research might fail and not lead to a working medicine
    • New drug could face legal or regulatory delays
    • Competition may copy their ideas after patent expires
  • Generic ManufacturersProduce cost-effective versions of patented drugs after patent expiry

    ▶

    In simple termsImagine you're making copies of your favorite toy, but instead of selling it as a new brand, you just call it 'the same toy' and sell it cheaper. That's what generic manufacturers do with medicines.

    What it is

    Generic manufacturers make medicines that are the same as branded drugs but sold at lower prices after the original patent expires. They copy the formula and produce it in bulk for hospitals, pharmacies, and other buyers.

    How it makes money

    They earn money by selling large quantities of these copied medicines to retailers, hospitals, and government programs. Since they don’t spend much on research, their costs are lower, so they can sell at a discount but still make profit.

    Where it sits in the chain

    Upstream: They buy raw materials and active pharmaceutical ingredients (APIs) from suppliers. Downstream: They sell finished medicines to pharmacies, hospitals, distributors, and sometimes directly to governments or health programs.

    Who plays here

    These are companies that specialize in making generic drugs. Some may also have a small number of branded products but focus mostly on copying approved medicines after patents expire. They often operate in large manufacturing facilities with strict quality controls.

    Economics & margins

    They have moderate costs for production and distribution, but high capital investment in factories and equipment. Margins are usually low to medium because competition is fierce. Their business can be cyclical due to changes in regulations or patent expirations.

    What a strong player looks like

    A strong player has a wide range of approved generic drugs, consistent sales growth, good relationships with large buyers like hospitals or governments, and a solid track record of meeting quality standards.

    Metrics that matter

    • Volume of drugs produced
    • Gross profit margin
    • Market share in key therapeutic areas
    • Number of generic products launched annually

    Key risks

    • Loss of patents for key products
    • Regulatory changes that affect approval processes
    • Price wars with competitors
    • Supply chain disruptions for raw materials
    • Quality control issues leading to recalls
• API / Bulk DrugsProduction of active pharmaceutical ingredients used in formulations

  ▶

  In simple termsImagine you're making a cake, and the flour is the API — it's the main ingredient that makes the cake taste good, but you don't eat the flour by itself. You need it to make the final product.

  What it is

  API / Bulk Drugs companies produce the basic chemical ingredients (called APIs) used in making medicines. These are not sold directly to patients; instead, they're sent to other companies that turn them into finished drugs like pills or syrups.

  How it makes money

  These companies sell their chemicals to drug manufacturers at a price that covers production costs and gives some profit. The more they can produce efficiently and the better they can control costs, the more money they make.

  Where it sits in the chain

  Upstream: They buy raw materials like chemicals or other basic ingredients from suppliers. Downstream: They sell their APIs to pharmaceutical companies that make finished medicines.

  Who plays here

  These are typically large chemical manufacturing firms that specialize in producing specific types of drugs at scale, often with strong relationships with global drug makers. Some may also have expertise in a particular class of medicine or a certain type of chemical process.

  Economics & margins

  They require significant upfront investment in factories and equipment (high capital intensity). Their costs are mostly fixed (like factory maintenance), so they need to run at high capacity to be profitable. Margins can vary, but they tend to be stable with some exposure to global price fluctuations. They may face cyclicality based on demand for certain drugs.

  What a strong player looks like

  A strong player has long-term contracts with big drug companies, efficient production processes, low costs, and a diverse range of products. It can adapt quickly to changes in demand and maintain good relationships with regulators and suppliers.

  Metrics that matter

  • Production volume
  • Cost per unit of production
  • Profit margin (gross and net)
  • Capacity utilization rate
  • Customer concentration (how many big clients they rely on)

  Key risks

  • Price competition from other API producers
  • Regulatory changes that affect what chemicals can be used
  • Supply chain disruptions for raw materials
  • Dependence on a few large customers
  • Environmental or safety violations leading to fines or shutdowns
  • API ProducersManufacture raw chemical components for drug formulation

    ▶

    In simple termsAPI producers are like cookie factories that make the special ingredients for cookies, but they don't actually bake the cookies themselves.

    What it is

    API producers make the basic chemical ingredients (called Active Pharmaceutical Ingredients) used in medicines. These are the building blocks that drug companies use to create finished products like pills or syrups.

    How it makes money

    They sell these chemicals to other companies, usually pharmaceutical firms, which then turn them into final medicines. The money comes from selling large quantities of these ingredients at a price higher than what it costs to make them.

    Where it sits in the chain

    Upstream: They buy raw materials and chemicals. Downstream: They sell to pharmaceutical companies that make finished drugs or other API producers who need more ingredients.

    Who plays here

    These are companies that specialize in making large amounts of specific chemical compounds used in medicines. Some may focus on a few types of APIs, while others might have a wide range of products for different kinds of drugs.

    Economics & margins

    They require significant investment in manufacturing plants and equipment (high capital intensity). Their costs include raw materials, energy, and labor. Margins are usually moderate to low due to competition, but they can be stable if they have long-term contracts with big buyers. They may face cyclicality based on demand for certain drugs.

    What a strong player looks like

    A strong API producer has long-term contracts with big pharmaceutical companies, efficient production processes, and a good reputation for quality. It may also have a diverse range of APIs to reduce risk.

    Metrics that matter

    • Revenue from API sales
    • Gross margin percentage
    • Capacity utilization rate (how much of their production is used)

    Key risks

    • Price competition from other API producers
    • Regulatory changes affecting what they can make
    • Supply chain disruptions for raw materials
    • Dependence on a few large customers
    • Environmental or safety violations
  • Bulk Drug ManufacturersProduce large quantities of intermediates and APIs for use by other companies

    ▶

    In simple termsImagine you're making cookies and you need flour, sugar, and butter. Bulk Drug Manufacturers are like the people who make those ingredients in big amounts so other bakers can use them to make different kinds of cookies.

    What it is

    Bulk Drug Manufacturers produce large quantities of raw materials used to make medicines. These materials are called Active Pharmaceutical Ingredients (APIs), which are the key parts that make a medicine work.

    How it makes money

    They sell these raw materials to other companies, like drug makers or generic manufacturers, who then turn them into finished medicines that people take.

    Where it sits in the chain

    Upstream: They buy chemicals and other basic ingredients. Downstream: They sell their bulk drugs to pharmaceutical companies, hospitals, or international buyers.

    Who plays here

    These are companies that specialize in making large amounts of medicine ingredients. Some may be owned by bigger drug companies, while others operate independently and supply many different customers.

    Economics & margins

    They need a lot of money upfront for equipment and facilities (high capital intensity). Their costs include raw materials, energy, and labor. Margins are usually moderate, and their business can be affected by changes in demand or regulations.

    What a strong player looks like

    A strong player has a stable and growing order book, good relationships with major pharmaceutical companies, consistent quality control, and the ability to adapt to new regulations or market demands.

    Metrics that matter

    • Volume of API produced per year
    • Percentage of revenue from international sales
    • Gross profit margin

    Key risks

    • Regulatory changes that affect production standards
    • Fluctuations in raw material prices
    • Competition from lower-cost producers
    • Supply chain disruptions
• CDMOContract development and manufacturing organization services for pharmaceutical products

  ▶

  In simple termsA CDMO is like a factory that makes medicines for other companies, just like a bakery bakes cakes for cafes.

  What it is

  CDMOs are companies that manufacture drugs or pharmaceutical products on behalf of other companies. They don’t sell the final product to customers; they make it for others who own the drug brand.

  How it makes money

  They get paid by the companies that want to sell the medicine, usually based on how much they produce and the complexity of the manufacturing process.

  Where it sits in the chain

  Upstream: They buy raw materials and ingredients from suppliers. Downstream: They sell finished products to pharmaceutical companies that own the drug brand.

  Who plays here

  These are contract manufacturers who specialize in making medicines for others. Some may focus on specific types of drugs, like generic medicines or complex biologics, and they often work with both Indian and global pharma firms.

  Economics & margins

  They have high upfront costs for equipment and facilities but lower ongoing costs once running. Margins are usually moderate to good, depending on the complexity of what they make. They can be affected by changes in demand from their clients.

  What a strong player looks like

  A strong CDMO has long-term contracts with big, stable clients, a good track record of meeting quality standards, and the ability to handle complex manufacturing tasks efficiently.

  Metrics that matter

  • Production volume
  • Number of contracts or clients
  • Profit margin percentage
  • On-time delivery rate

  Key risks

  • Loss of major client contracts
  • Regulatory issues that stop production
  • Rising costs of raw materials
  • Competition from lower-cost manufacturers
  • CDMOsProvide end-to-end drug development and manufacturing services to other companies

    ▶

    In simple termsCDMOs are like cookie factories that make cookies for other people's bakeries. They don't sell the cookies themselves, but they help other companies make them.

    What it is

    CDMOs, or Contract Development and Manufacturing Organizations, are companies that help pharmaceutical companies develop and make their medicines. They do everything from creating the formula to producing the final product in large quantities.

    How it makes money

    They get paid by pharmaceutical companies to design, test, and manufacture drugs. The more drugs they make for others, the more money they earn.

    Where it sits in the chain

    Upstream: They buy raw materials and lab equipment from suppliers. Downstream: They sell finished medicines or development services to pharmaceutical companies.

    Who plays here

    These are specialized manufacturing firms that focus on making drugs for other companies. Some may also help with drug research and testing before production starts.

    Economics & margins

    They need a lot of expensive machines and skilled workers, so they have high upfront costs. Their profits depend on how many drugs they make and the prices they charge. They can be affected by changes in demand from pharmaceutical companies.

    What a strong player looks like

    A strong CDMO has long-term contracts with big pharmaceutical companies, uses modern technology, and can handle complex drug manufacturing. It also has a good track record of meeting quality standards.

    Metrics that matter

    • Number of products manufactured
    • Revenue per customer
    • Production capacity utilization
    • R&D investment as a percentage of revenue

    Key risks

    • Loss of major customers
    • Regulatory issues that delay production
    • High costs of maintaining advanced equipment
    • Competition from lower-cost regions
• HospitalsProvision of inpatient and outpatient medical care services

  ▶

  In simple termsHospitals are like big, busy stores where instead of selling toys or food, they help people feel better when they're sick or hurt.

  What it is

  Hospitals are buildings with doctors, nurses, and special equipment that treat patients who are ill or injured. They provide care for everything from broken bones to serious diseases.

  How it makes money

  Hospitals earn money by charging patients or their insurance companies for the services they provide, like check-ups, surgeries, and staying in a room overnight.

  Where it sits in the chain

  Upstream: Hospitals buy medicines, medical devices, and supplies from manufacturers. Downstream: They serve patients directly, as well as doctors who refer them, and insurance companies that pay for care.

  Who plays here

  There are public hospitals run by the government, private hospitals owned by families or groups, and chain hospitals that have multiple locations in different cities. Some focus on specific types of care like heart surgery or maternity.

  Economics & margins

  Hospitals need a lot of money to build and maintain their buildings and equipment, so they are capital-intensive. They usually have moderate profit margins because costs like staff salaries and medical supplies are high. Their business can be affected by things like government policies or economic downturns.

  What a strong player looks like

  A strong hospital has a good reputation, high patient satisfaction, modern equipment, and consistent revenue. It might have a clear focus on certain types of care and be able to handle both routine and complex cases.

  Metrics that matter

  • Number of patients treated per month
  • Average length of stay for inpatients
  • Patient satisfaction scores
  • Bed occupancy rate
  • Revenue per bed

  Key risks

  • High operating costs that can eat into profits
  • Regulatory changes affecting how they operate
  • Competition from other hospitals or clinics
  • Medical malpractice lawsuits
  • Fluctuations in insurance reimbursements
• DiagnosticsTesting and analysis for disease detection, monitoring, and prevention

  ▶

  In simple termsDiagnostics is like a detective who finds out what's wrong with your body, just like a doctor might look at a puzzle to figure out the answer.

  What it is

  Diagnostics companies help doctors find out if someone is sick by testing their blood, urine, or other samples. They use special machines and tools to look for signs of disease or health problems.

  How it makes money

  They sell tests, test kits, and services to hospitals, clinics, and labs. Some also run their own labs where they do the tests for patients directly.

  Where it sits in the chain

  Upstream: They buy chemicals, machines, and equipment from manufacturers. Downstream: They sell their tests and services to hospitals, clinics, and independent labs.

  Who plays here

  There are big companies that make test kits and machines, smaller labs that run tests for doctors, and some companies that offer mobile testing services in rural areas.

  Economics & margins

  They have moderate costs because they need machines and chemicals. They can be capital-intensive if they invest in expensive equipment. Margins vary — bigger companies may have better margins due to scale, but the industry is competitive.

  What a strong player looks like

  A strong diagnostics company has reliable, accurate test results, good relationships with hospitals and labs, and can adapt to new technology. It also has steady growth in the number of tests it performs.

  Metrics that matter

  • Number of tests performed per month
  • Cost per test
  • Growth in lab locations or test volume
  • Customer retention rate (e.g., repeat business from hospitals)

  Key risks

  • Regulatory changes that affect how tests are approved
  • Competition from cheaper or better alternatives
  • Dependence on a few large customers like big hospitals
  • Rapid technological change making older equipment obsolete
  • Diagnostic LabsOffer laboratory testing services to patients and healthcare providers

    ▶

    In simple termsThink of diagnostic labs like a detective's office where they look for clues to find out what's wrong with your body, just like a detective finds clues to solve a mystery.

    What it is

    Diagnostic labs are places where doctors send samples from patients—like blood or urine—to test and figure out what illness or condition someone has. They use special machines and trained people to run these tests.

    How it makes money

    They charge hospitals, clinics, and sometimes even individuals for running the tests. The more tests they do, the more money they make.

    Where it sits in the chain

    Upstream: They buy chemicals, reagents, and equipment from suppliers. Downstream: They sell their test results to doctors, hospitals, and patients.

    Who plays here

    There are large national labs that operate in many cities, smaller regional labs that serve specific areas, and some hospital-owned labs that do tests for the patients at their own facility.

    Economics & margins

    They need a lot of expensive equipment and trained staff, so they have high upfront costs. Their profit margins are moderate because they compete on price and speed. They can be affected by changes in healthcare policies or insurance coverage.

    What a strong player looks like

    A strong diagnostic lab has consistent test volume, good relationships with doctors, up-to-date equipment, and a reputation for fast and accurate results.

    Metrics that matter

    • Number of tests performed per month
    • Average cost per test
    • Percentage of repeat customers or referrals from doctors

    Key risks

    • Regulatory changes that affect how labs operate
    • Competition from new labs or cheaper alternatives
    • Failure to maintain accurate testing standards
    • Dependence on a few large hospital clients
  • Medical Device ManufacturersProduce diagnostic equipment and tools used in clinical settings

    ▶

    In simple termsImagine you have a toy that helps fix broken things, like a special screwdriver that can check if your bike is working. Medical device manufacturers make tools that doctors use to help sick people feel better.

    What it is

    Medical Device Manufacturers are companies that design, build, and sell tools or machines used by doctors and nurses to diagnose illnesses, treat patients, or monitor their health. These can be things like X-ray machines, heart monitors, surgical instruments, or even artificial limbs.

    How it makes money

    They make money by selling these medical devices to hospitals, clinics, and healthcare providers. They might also sell replacement parts, maintenance services, or software that works with the devices.

    Where it sits in the chain

    Upstream: They buy materials like metal, plastic, and electronics from suppliers. Downstream: They sell their products to hospitals, doctors' offices, and sometimes directly to patients through retailers or online platforms.

    Who plays here

    There are large global companies that make a wide range of devices, smaller local firms that focus on specific tools like blood pressure monitors or glucose meters, and some Indian companies that specialize in affordable, high-quality equipment for the domestic market.

    Economics & margins

    These businesses have moderate costs because they need to invest in research, development, and manufacturing. They require some capital for production but not as much as big pharmaceutical companies. Profit margins are usually good if they can sell their products at a premium or scale up efficiently.

    What a strong player looks like

    A strong company has a clear line of products that are widely used, consistent sales growth, good relationships with hospitals and doctors, and the ability to keep improving its devices over time.

    Metrics that matter

    • Revenue growth
    • Gross margin percentage
    • Number of devices sold annually
    • Market share in specific device categories

    Key risks

    • Regulatory changes that affect product approval
    • Competition from cheaper or better alternatives
    • Supply chain disruptions for critical components
    • Failure to innovate and stay relevant
• Healthcare ServicesNon-hospital-based medical care, including telemedicine and home healthcare

  ▶

  In simple termsThink of it like a restaurant that serves food to sick people instead of hungry ones. The kitchen makes the meals (like doctors and nurses), and the waiters help you get your food (like support staff).

  What it is

  Healthcare Services are businesses that provide medical care directly to patients, such as hospitals, clinics, diagnostic labs, and home healthcare services. These companies offer treatments, check-ups, surgeries, and other health-related services.

  How it makes money

  They charge patients or insurance companies for the services they provide. For example, a hospital might bill a patient for a surgery, or a lab might charge for blood tests.

  Where it sits in the chain

  Upstream: They buy medical equipment, drugs, and supplies from manufacturers. Downstream: They sell their services to patients, insurance companies, and sometimes government programs.

  Who plays here

  ['Hospitals that offer inpatient and outpatient care', 'Diagnostic labs that run tests like blood work or X-rays', 'Clinics that provide basic medical check-ups and treatments', "Home healthcare agencies that send nurses or caregivers to patients' homes"]

  Economics & margins

  These businesses have high operating costs due to the need for skilled staff, equipment, and facilities. They are capital-intensive (need a lot of money upfront), but can have moderate profit margins if they manage costs well. Their performance is not highly cyclical, as people always need healthcare.

  What a strong player looks like

  A strong player in this space has a good reputation, consistent patient flow, efficient operations, and stable revenue. It might have modern facilities, trained staff, and positive reviews from patients.

  Metrics that matter

  • Patient admission rates or number of consultations per day
  • Average revenue per patient visit
  • Occupancy rate of hospital beds or clinic slots
  • Cost per procedure or service

  Key risks

  • Regulatory changes that affect how they can operate or charge for services
  • Rising costs of medical supplies and staff wages
  • Competition from other healthcare providers
  • Decreased insurance reimbursements or patient out-of-pocket payments
• Pharma DistributionLogistics and supply chain management for pharmaceutical products

  ▶

  In simple termsPharma distribution is like a delivery person who brings medicines from the factory to the local pharmacy, just like how a pizza delivery person brings food from the restaurant to your home.

  What it is

  Pharma distributors are companies that buy medicines from manufacturers and then sell them to pharmacies, hospitals, and clinics. They act as a middleman between drug makers and healthcare providers.

  How it makes money

  They make money by buying medicines at a lower price from the manufacturer and selling them at a slightly higher price to the end customer, like a pharmacy or hospital.

  Where it sits in the chain

  Upstream: they buy medicines from pharmaceutical manufacturers. Downstream: they sell these medicines to pharmacies, hospitals, clinics, and sometimes even directly to patients through retail outlets.

  Who plays here

  These are companies that specialize in logistics and sales of medicines. They may be independent distributors or part of larger healthcare groups. Some have a national presence, while others operate regionally.

  Economics & margins

  They have low capital intensity because they don’t manufacture drugs. Their costs include transportation, storage, and inventory management. Margins are typically modest (around 5-10%), and their business can be affected by changes in government policies or drug pricing regulations.

  What a strong player looks like

  A strong distributor has a wide network of reliable customers, stable relationships with manufacturers, efficient logistics, and consistent sales growth. It can handle fluctuations in demand without major losses.

  Metrics that matter

  • Gross margin percentage
  • Inventory turnover ratio
  • Number of retail outlets served
  • Customer retention rate

  Key risks

  • Regulatory changes affecting drug pricing
  • Supply chain disruptions
  • Competition from large pharmacy chains or online platforms
  • Credit risk from selling to small clinics or pharmacies
  • Wholesalers / DistributorsSupply drugs to pharmacies, hospitals, and clinics

    ▶

    In simple termsImagine you have a lemonade stand, and you buy big bottles of lemonade from a factory and then sell them to other stands or stores so they can sell it to people. That's what wholesalers do with medicine.

    What it is

    Wholesalers / Distributors are companies that buy medicines in large quantities from manufacturers (like drug companies) and then sell them to pharmacies, hospitals, clinics, or smaller retailers who need the medicines to sell to patients.

    How it makes money

    They make money by buying medicine at a lower price from manufacturers and selling it at a slightly higher price to their customers. The difference between what they pay and what they charge is called profit.

    Where it sits in the chain

    Upstream, they buy from pharmaceutical manufacturers. Downstream, they sell to pharmacies, hospitals, clinics, and sometimes even directly to patients in some cases.

    Who plays here

    These are companies that specialize in moving medicine efficiently across the country. They might be large national players with many warehouses or smaller regional ones focused on specific areas. Some may also handle logistics like transportation and storage.

    Economics & margins

    They have moderate costs because they need to store medicines, hire people, and transport them. They don’t require a lot of upfront money compared to manufacturers but do need good relationships and reliable supply chains. Their profit margins are usually low (around 5-10%) and can be affected by changes in regulations or competition.

    What a strong player looks like

    A strong distributor has a wide network of reliable customers, good relationships with manufacturers, efficient logistics, and can keep medicines available even during tough times. They also have stable profit margins and don’t rely too much on any single customer or product.

    Metrics that matter

    • Number of outlets served
    • Inventory turnover ratio
    • Gross margin percentage

    Key risks

    • Supply chain disruptions due to regulatory issues or shortages
    • Competition from larger players or direct sales models
    • Changes in government pricing policies
    • Inability to maintain consistent inventory levels
• Health InsuranceFinancial protection against medical expenses

  ▶

  In simple termsHealth insurance is like a safety net that helps you pay for doctor visits and medicines when you're sick, just like how a raincoat keeps you dry when it rains.

  What it is

  Health insurance companies provide financial protection to people by covering the cost of medical treatments, hospital stays, and sometimes even preventive care. They help individuals or groups pay for healthcare expenses that can be very expensive.

  How it makes money

  These companies collect regular payments called premiums from customers. They use some of this money to pay for the health care costs of their policyholders, and keep the rest as profit if they don't have to pay out too much.

  Where it sits in the chain

  Upstream, they work with hospitals, doctors, and pharmacies to arrange care. Downstream, they sell policies directly to individuals or through employers, agents, or brokers.

  Who plays here

  ['Private health insurance companies that offer individual or group plans', 'Public sector insurers that provide government-sponsored health coverage', 'Third-party administrators (TPAs) that manage claims and customer service for insurers']

  Economics & margins

  Health insurance has high fixed costs due to the need for large administrative systems, but low capital intensity because they don't own hospitals or clinics. Margins are typically moderate, and the business can be cyclical depending on health trends and economic conditions.

  What a strong player looks like

  A strong health insurance company has a large, loyal customer base, stable claim ratios, good relationships with hospitals and doctors, and clear communication about what is covered in their policies.

  Metrics that matter

  • Premium income (how much money is collected from customers)
  • Claim ratio (percentage of premiums paid out as medical expenses)
  • Customer retention rate (how many people keep their policy year after year)

  Key risks

  • High claim ratios that reduce profit
  • Rising healthcare costs that make it harder to predict and manage payouts
  • Regulatory changes that affect what services are covered or how premiums can be set
  • Competition from new players or government programs